Holen Sie sich die Stockscreener-App
1.33
1.53%
0.02
Handel nachbörslich:
1.34
0.01
+0.75%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTXR?
Forum
Prognose
Aktiensplit
Citius Pharmaceuticals Inc Aktie (CTXR) Neueste Nachrichten
Citius Pharmaceuticals Q3 Earnings: Net Loss Narrows, Revenue Falls Short of Expectations. - AInvest
Citius Pharmaceuticals regains Nasdaq compliance with minimum bid price requirement. - AInvest
Citius Pharmaceuticals Inc. Uptrend in Early Stages Indicators Say YesPortfolio Value Report & Consistent Income Trade Ideas - thegnnews.com
Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update - The Malaysian Reserve
Citius Posts Wider Loss in Fiscal Q3 - The Globe and Mail
Citius: D. Boral Capital raises PT to $6, maintains Buy rating. - AInvest
Citius Pharmaceuticals shares fall 3.85% intraday after reporting fiscal third quarter results and raising $12.5 million in financings. - AInvest
Citius Oncology Beats Q3 EPS Estimates with $0 Revenue - AInvest
Citius Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Citius Oncology (CTOR) $9M Offering; Cash Runway Through Sept 2025 | TENKU SEC FilingForm 10-Q - Stock Titan
Citius Oncology Secures $21.5M Funding to Launch New Lymphoma Treatment LYMPHIR - Stock Titan
Why Citius Pharmaceuticals Inc. stock attracts strong analyst attention2x Return in 30 Days Picks - 한국정경신문
Citius Oncology Announces Pricing of $9.0 Million Public Offering - ADVFN Brasil
Chart overlay techniques for tracking Citius Pharmaceuticals Inc.Swing Trade Entry and Exit Point Analysis - Newser
Tools to assess Citius Pharmaceuticals Inc.’s risk profileVolume Spike Detection for Early Breakouts - Newser
Sector ETF performance correlation with Citius Pharmaceuticals Inc.Risk Shielded Trade Watch with Analysis - Newser
Is Citius Pharmaceuticals Inc. stock a growth or value playWeekly Breakout Forecast with Entry Zones - Newser
Citius Pharmaceuticals (CTXR) Expected to Announce Quarterly Earnings on Monday - Defense World
Citius CTXR 2025Q3 Earnings Preview Upside Ahead on Potential New Product Launch - AInvest
Why Citius Pharmaceuticals Inc. is moving todaySummary of Reliable Long-Term Trade Models - Newser
Published on: 2025-08-04 16:39:39 - beatles.ru
Published on: 2025-08-04 09:23:45 - beatles.ru
What is the dividend policy of Citius Pharmaceuticals Inc. stockMaximize your gains with expert trading tips - Jammu Links News
When is Citius Pharmaceuticals Inc. stock expected to show significant growthSpectacular growth rates - Jammu Links News
What are Citius Pharmaceuticals Inc. company’s key revenue driversUnstoppable trading performance - Jammu Links News
What institutional investors are buying Citius Pharmaceuticals Inc. stockAchieve breakthrough investment performance - Jammu Links News
Is Citius Pharmaceuticals Inc. a good long term investmentExceptional ROI - Jammu Links News
Why is Citius Pharmaceuticals Inc. stock attracting strong analyst attentionExceptional trading performance - Jammu Links News
What makes Citius Pharmaceuticals Inc. stock price move sharplyTrack stocks with high upside potential easily - Jammu Links News
How many analysts rate Citius Pharmaceuticals Inc. as a “Buy”Accelerated investment success - Jammu Links News
How does Citius Pharmaceuticals Inc. compare to its industry peersFree Stock Watchlist For Fast Growth - Jammu Links News
What are the technical indicators suggesting about Citius Pharmaceuticals Inc.Chart Pattern Trend Scanner With Low Risk - Jammu Links News
What is Citius Pharmaceuticals Inc. company’s growth strategyRetirement Planning Review With Proven Results - Jammu Links News
Is Citius Pharmaceuticals Inc. reversing from oversold territoryIntraday Trend Analysis for Fast Gains Released - metal.it
Citius Pharmaceuticals Inc. Chart Enters High Volatility ZoneCommunity Entry Consensus Trade Ideas Shared - metal.it
Wyckoff Accumulation Phase Possible in Citius Pharmaceuticals Inc.Weekly Chart Analysis With Entry Advice Provided - metal.it
Is Citius Pharmaceuticals Inc. stock overvalued or undervaluedRapid portfolio appreciation - Jammu Links News
Is it the right time to buy Citius Pharmaceuticals Inc. stockBuild wealth steadily with expert advice - Jammu Links News
What is the risk reward ratio of investing in Citius Pharmaceuticals Inc. stockBreakout profit opportunities - Jammu Links News
What are analysts’ price targets for Citius Pharmaceuticals Inc. in the next 12 monthsDiscover breakthrough stocks with expert help - Jammu Links News
How Citius Pharmaceuticals Inc. stock performs during market volatilityFree Stock Trading Signals - metal.it
What analysts say about Citius Pharmaceuticals Inc. stockFree Investment Community - printweek.in
Citius Pharmaceuticals Inc. Stock Analysis and ForecastLightning-fast growth - Autocar Professional
Citius Oncology Announces Closing of $9.0 Million Public Offering - StreetInsider
What drives Citius Pharmaceuticals Inc. stock priceSuperior risk-adjusted returns - jammulinksnews.com
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):